What is EvoNext Holdings SA (EVE.SW) stock price today?

EvoNext Holdings SA (EVE.SW) is currently trading at $2.08, down 3.26% today.

What is EVE.SW P/E ratio?

EvoNext Holdings SA's P/E ratio is -23.11. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EVE.SW return on equity (ROE)?

EvoNext Holdings SA's return on equity (ROE) is -10.41%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is EvoNext Holdings SA's market cap?

EvoNext Holdings SA has a market capitalization of $15.00M.

EBS · Shell Companies

EvoNext Holdings SA (EVE.SW) Stock

$2.08 -3.26% EBS: EVE.SW Financial Services

Valuation

Metric	Value
Price	$2.08
Market Cap	$15.00M
P/E Ratio	-23.11
P/B Ratio	2.52
P/S Ratio	—
EPS (TTM)	$-0.09
52-Week High	$2.74
52-Week Low	$0.75
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-10.41%
ROA	-4.40%
ROCE	—
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	—
Current Ratio	8.31

Latest News

Solar A/S: No. 12 2026 All key markets returned to growth, outlook reconfirmed GlobeNewswire · Aug 13, 2026 Interim Report Q2 2026 GlobeNewswire · Aug 13, 2026 India's Black Box secures $131 million data centre order from U.S. hyperscaler Reuters · Aug 13, 2026 Skanska signs an additional contract for a data center in Virginia, USA, worth USD 238M, about SEK 2.2 billion PR Newswire · Aug 13, 2026 Upgrade of guidance for full year 2026 GlobeNewswire · Aug 13, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	—
Quick Ratio	8.05
Interest Coverage	—
Return 1Y	95.45%
Return 3Y	-46.12%
Return 5Y	-94.91%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ADXN.SWAddex Therapeutics Ltd	$0.04	+0.00%	—	—	0.00%
BSLN.SWBasilea Pharmaceutica AG	$52.60	+2.33%	—	—	0.00%
MOLN.SWMolecular Partners AG	$3.26	+0.31%	—	—	0.00%
NWRN.SWNewron Pharmaceuticals S.p.A.	$11.72	-4.72%	—	—	0.00%
SANN.SWSanthera Pharmaceuticals Holding AG	$15.88	+2.45%	—	—	0.00%

About EvoNext Holdings SA

EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors. The company was formerly known as Evolva Holding SA and changed its name to EvoNext Holdings SA in July 2025. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

EvoNext Holdings SA (EVE.SW) stock trades at $2.08 with a market capitalization of $15.00M. The stock is valued at a price-to-earnings (P/E) ratio of -23.11, price-to-book of 2.52. Over the past 52 weeks the stock has ranged between $0.75 and $2.74, and currently trades 24.1% below its 52-week high.

On profitability, EvoNext Holdings SA generates a return on equity (ROE) of -10.41%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: evonextholdings.com